Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Viridal Duo Starter Pack 40microgram powder and solvent for solution for injection cartridges with device (Advanz Pharma) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alprostadil 40microgram powder and solvent for solution for injection cartridges with device 1 cartridge |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alprostadil 20microgram powder and solvent for solution for injection cartridges with device 1 cartridge |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alprostadil 10microgram powder and solvent for solution for injection cartridges with device 1 cartridge |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Viridal Duo Starter Pack 10microgram powder and solvent for solution for injection cartridges with device (Advanz Pharma) 2 cartridge |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Viridal Duo Starter Pack 20microgram powder and solvent for solution for injection cartridges with device (Advanz Pharma) 2 cartridge |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Viridal Duo Starter Pack 40microgram powder and solvent for solution for injection cartridges with device (Advanz Pharma) 2 cartridge |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspirin 500mg powder and solvent for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspirin 1g powder and solvent for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspegic Injectable 500mg powder and solvent for solution for injection vials (sanofi-aventis) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspegic Injectable 1g powder and solvent for solution for injection vials (sanofi-aventis) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspirin 1g powder and solvent for solution for injection vials 20 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspirin 1g powder and solvent for solution for injection vials 6 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspirin 500mg powder and solvent for solution for injection vials 20 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspirin 500mg powder and solvent for solution for injection vials 6 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspegic Injectable 500mg powder and solvent for solution for injection vials (sanofi-aventis) 6 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspegic Injectable 500mg powder and solvent for solution for injection vials (sanofi-aventis) 20 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspegic Injectable 1g powder and solvent for solution for injection vials (sanofi-aventis) 6 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aspegic Injectable 1g powder and solvent for solution for injection vials (sanofi-aventis) 20 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Secretin 20microgram powder and solvent for solution for injection ampoules |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Secrelux 20microgram powder and solvent for solution for injection ampoules (Sanochemia Diagnostics Deutschland GmbH) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Secretin 20microgram powder and solvent for solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Secrelux 20microgram powder and solvent for solution for injection ampoules (Sanochemia Diagnostics Deutschland GmbH) 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Thiopental 500mg powder for solution for injection vials (Link Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Thiopental 500mg powder for solution for injection vials (Link Pharmaceuticals Ltd) 25 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Abatacept 250mg powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Abatacept 250mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Etoposide 100mg powder for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 15mg powder for solution for injection ampoules |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 15mg powder for solution for injection ampoules (Special Order) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 15mg powder for solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine 15mg powder for solution for injection ampoules (Special Order) 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Follitropin alfa 150unit / Lutropin alfa 75unit powder and solvent for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pergoveris 150unit / 75unit powder and solvent for solution for injection vials (Merck Pharmaceuticals) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Follitropin alfa 150unit / Lutropin alfa 75unit powder and solvent for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Follitropin alfa 150unit / Lutropin alfa 75unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pergoveris 150unit / 75unit powder and solvent for solution for injection vials (Merck Pharmaceuticals) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pergoveris 150unit / 75unit powder and solvent for solution for injection vials (Merck Pharmaceuticals) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Antithrombin alfa 1750units powder for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
ATryn 1750units powder for solution for infusion vials (LEO Pharma) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Antithrombin alfa 1750units powder for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
ATryn 1750units powder for solution for infusion vials (LEO Pharma) 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium nitroprusside 50mg powder for solution for injection vials (UniChem Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium nitroprusside 50mg powder for solution for injection vials (UniChem Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Anidulafungin 100mg powder and solvent for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ecalta 100mg powder and solvent for concentrate for solution for infusion vials (Pfizer Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Anidulafungin 100mg powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ecalta 100mg powder and solvent for concentrate for solution for infusion vials (Pfizer Ltd) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nonacog alfa 2,000unit powder and solvent for solution for injection vials |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BeneFIX 2,000unit powder and solvent for solution for injection vials (Wyeth Pharmaceuticals) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nonacog alfa 2,000unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BeneFIX 2,000unit powder and solvent for solution for injection vials (Wyeth Pharmaceuticals) 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aciclovir 250mg powder for solution for infusion vials (Wockhardt UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aciclovir 250mg powder for solution for infusion vials (Wockhardt UK Ltd) 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoprostenol 1.5mg powder and solvent for infusion vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tenecteplase 8000iu(40mg) powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tenecteplase 10,000iu(50mg) inj (pdr for recon)+solvent |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Zoledronic acid 4mg powder and solvent for infusion vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Rasburicase 1.5mg powder and solvent for infusion vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely imiglucerase 400 unit/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely porfimer sodium 15 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Omeprazole 40mg powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Omeprazole 40mg powder for infusion solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Digoxin specific antibody 40mg injection (pdr for recon) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hydralazine hydrochloride 20mg injection powder vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoprostenol 500micrograms powder and solvent for infusion vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Streptokinase 1.5million iu powder for infusion solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Streptokinase 250,000iu powder for infusion solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Streptokinase 750,000iu powder for infusion solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alteplase 50mg powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alteplase 20mg powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alteplase 10mg powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Reteplase 10units powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Recombinant coagulation factor IX 250iu powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Recombinant coagulation factor IX 500iu powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Recombinant coagulation factor IX 1000iu powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Recombinant coagulation factor VIIa 60,000iu powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Recombinant coagulation factor VIIa 120,000iu powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Recombinant coagulation factor VIIa 240,000iu powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Factor VIII 500iu/von Willebrand factor 1100iu powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Factor VIII 1000iu/von Willebrand factor 2200iu powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Factor XIII 250units powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Diamorphine hydrochloride 5mg injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely diamorphine hydrochloride 10 milligram/1 ampule powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely diamorphine hydrochloride 30 milligram/1 ampule powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely diamorphine hydrochloride 100 milligram/1 ampule powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely diamorphine hydrochloride 500 milligram/1 ampule powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium valproate 400mg powder and solvent for injection solution vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely botulinum toxin type A 500 unit/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzylpenicillin sodium 600 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely flucloxacillin (as flucloxacillin sodium) 1 gram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 1 gram and clavulanic acid (as clavulanate potassium) 200 milligram/1 vial powder for conventional release solution for injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|